Unknown

Dataset Information

0

Vascular endothelial growth factor receptor 2 (VEGFR-2) plays a key role in vasculogenic mimicry formation, neovascularization and tumor initiation by Glioma stem-like cells.


ABSTRACT: Human glioblastomas (GBM) are thought to be initiated by glioma stem-like cells (GSLCs). GSLCs also participate in tumor neovascularization by transdifferentiating into vascular endothelial cells. Here, we report a critical role of GSLCs in the formation of vasculogenic mimicry (VM), which defines channels lined by tumor cells to supply nutrients to early growing tumors and tumor initiation. GSLCs preferentially expressed vascular endothelial growth factor receptor-2 (VEGFR-2) that upon activation by VEGF, mediated chemotaxis, tubule formation and increased expression of critical VM markers by GSLCs. Knockdown of VEGFR-2 in GSLCs by shRNA markedly reduced their capacity of self-renewal, forming tubules, initiating xenograft tumors, promoting vascularization and the establishment of VM. Our study demonstrates VEGFR-2 as an essential molecule to sustain the "stemness" of GSLCs, their capacity to initiate tumor vasculature, and direct initiation of tumor.

SUBMITTER: Yao X 

PROVIDER: S-EPMC3594239 | biostudies-literature | 2013

REPOSITORIES: biostudies-literature

altmetric image

Publications

Vascular endothelial growth factor receptor 2 (VEGFR-2) plays a key role in vasculogenic mimicry formation, neovascularization and tumor initiation by Glioma stem-like cells.

Yao Xiaohong X   Ping Yifang Y   Liu Ying Y   Chen Kequiang K   Yoshimura Teizo T   Liu Mingyong M   Gong Wanghua W   Chen Chong C   Niu Qin Q   Guo Deyu D   Zhang Xia X   Wang Ji Ming JM   Bian Xiuwu X  

PloS one 20130311 3


Human glioblastomas (GBM) are thought to be initiated by glioma stem-like cells (GSLCs). GSLCs also participate in tumor neovascularization by transdifferentiating into vascular endothelial cells. Here, we report a critical role of GSLCs in the formation of vasculogenic mimicry (VM), which defines channels lined by tumor cells to supply nutrients to early growing tumors and tumor initiation. GSLCs preferentially expressed vascular endothelial growth factor receptor-2 (VEGFR-2) that upon activati  ...[more]

Similar Datasets

| S-EPMC5612353 | biostudies-literature
| S-EPMC4791658 | biostudies-other
| S-EPMC6371528 | biostudies-literature
| S-EPMC6714586 | biostudies-literature
| S-EPMC6872754 | biostudies-literature
| S-EPMC7247597 | biostudies-literature
| S-EPMC7507322 | biostudies-literature
| S-EPMC6536414 | biostudies-literature
| S-EPMC5190048 | biostudies-literature
| S-EPMC5482624 | biostudies-literature